UBS Raises Price Target on UnitedHealth Group (UNH) Following Investor Day

November 30, 2016 9:49 AM EST
Get Alerts UNH Hot Sheet
Price: $158.70 +0.61%

Rating Summary:
    25 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 37 | New: 34
Trade UNH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

UBS reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $193.00 (from $180.00), following the company's investor day. UNH expects its Medicare Advantage enrollment to grow by 700-800K lives in 2017, a 19-22% Y/Y increase. UBS raised 2016 EPS estimates to $9.45 and 2017 EPS estimates to $10.70.

Analyst A.J. Rice commented, "UNH struck a very positive tone at its investor day. The 2017 adj EPS outlook of $9.30-$9.60 represents Y/Y growth of 16-20%. With respect to the Y/Y EPS tailwind, UNH highlighted roughly $0.25 tailwind from downsizing public exchanges and another $0.25 tailwind related to the HIF moratorium. The remaining $0.80-$1.10 of Y/Y EPS growth is due to the strong performance of the key underlying business. Separately, UNH expects its commercial medical cost trend of 5.5-6.5% in 2017, vs 6% in 2016."

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $157.59 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities


Add Your Comment